Candel Therapeutics (CADL) EBIT Margin (2020 - 2023)
Candel Therapeutics (CADL) recorded EBIT Margin of -26132.26% in Q4 2022, down 1164.52 percentage points from -24967.74% a year earlier but up 2516.13 percentage points from the prior quarter.
Powered by 
Analysis
Candel Therapeutics (CADL) EBIT Margin (2020 - 2023) Analysis & Trends
For FY2022, Candel Therapeutics reported EBIT Margin of -27777.60%, down 7196.80 percentage points from FY2021.
- Across earlier years, EBIT Margin came in at -20580.80% in FY2021 (-9532.80 pp) and -11048.00% in FY2020.
- Quarterly EBIT Margin has ranged from -28987.10% in Q1 2022 to -8448.39% in Q2 2020 over the past five years.
- On a year-over-year basis, EBIT Margin has declined for seven consecutive quarters, with an average year-over-year change of -8558.06 percentage points over the last seven quarters.
- Per Business Quant, the preceding three quarters came in at -28648.39% (Q3 2022), -28235.48% (Q2 2022) and -28987.10% (Q1 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,170.90 Bn | 1,139.49 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 643.26 Bn | 561.78 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 501.85 Bn | 474.96 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 370.72 Bn | 325.10 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 302.56 Bn | 266.55 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 268.35 Bn | 242.04 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 242.39 Bn | 197.79 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 193.22 Bn | 167.42 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 172.25 Bn | 118.90 Bn | 10.94 Bn | 28.37% |
| 10 | Candel Therapeutics | 627.89 Mn | 118.95 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | -9,444.12% |
| Dec 31, 2022 | -26,132.26% |
| Sep 30, 2022 | -28,648.39% |
| Jun 30, 2022 | -28,235.48% |
| Mar 31, 2022 | -28,987.10% |
| Dec 31, 2021 | -24,967.74% |
| Sep 30, 2021 | -25,900.00% |
| Jun 30, 2021 | -17,100.00% |
| Mar 31, 2021 | -15,022.58% |
| Dec 31, 2020 | -19,758.06% |
| Sep 30, 2020 | -8,867.74% |
| Jun 30, 2020 | -8,448.39% |
API Access
Candel Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=CADL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "CADL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=CADL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();